Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.
EP: 1.Understanding CML: Your Journey from Diagnosis to Treatment
EP: 2.Navigating CML: Tools to Empower Patients and Caregivers
EP: 3.Empowering CML Caregivers: Strategies and Support Systems
EP: 4.Starting CML Treatment: Collaborative Choices for Better Outcomes
Now Viewing
EP: 5.Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life
EP: 6.When CML Therapy Shifts: Collaborative Approaches to Treatment Changes
EP: 7.CML Treatment: Scenarios that Necessitate Switching Therapy
EP: 8.Ensuring Informed CML Care from Diagnosis Onward
EP: 9.Advancing CML Management Towards an Ideal Patient Journey
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following questions:
- What are some of the most common concerns or questions newly diagnosed CML patients may have about their initial treatment plan?
- What are some common adverse effects or tolerability challenges patients may experience with their initial treatment plan?
- What is your best practice to set clear expectations with your patients on what they may experience along their CML journey?
Recent Videos
Related Content
Acalabrutinib Plus Venetoclax Offers PFS Advantage Over Standard Therapy in Frontline CLL
July 29th 2024Article
A fixed-duration treatment combining acalabrutinib and venetoclax, with or without obinutuzumab, significantly extended progression-free survival in patients with previously untreated chronic lymphocytic leukemia.
